Financings Of The Fortnight: Life Sciences IPO Wave Continuing Apace
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite warnings of a slowdown in the IPO market for life sciences firms, the past two weeks saw another wave of S-1 filings by biopharmaceutical companies. Scynexis adjusted goals for its planned IPO, while Corium completed its offering; meanwhile, Endocyte landed a huge FOPO and scPharmaceuticals got off the ground with a $16 million Series A round.